
PDE
Phosphodiesterases (PDEs) are enzymes that hydrolyze cyclic nucleotides, such as cAMP and cGMP, into their inactive forms, playing a key role in regulating intracellular signaling pathways. PDE inhibitors are used in the treatment of various conditions, including cardiovascular diseases, erectile dysfunction, and respiratory disorders, due to their ability to modulate cyclic nucleotide levels. At CymitQuimica, we provide a range of PDE inhibitors to support your research in cell signaling, pharmacology, and therapeutic development.
Found 169 products of "PDE"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
(1R,2R)-MK-8189
CAS:(1R,2R)-MK-8189 is an isomer of MK-8189, a potent and selective pyrimidine PDE10A inhibitor.Formula:C19H22N6OSPurity:>99.99% - >99.99%Color and Shape:SoildMolecular weight:382.48PDE5-IN-9
CAS:WAY-639921 treats cardiovascular and respiratory conditions by inhibiting PDE1c.Formula:C18H14N4SPurity:99.98%Color and Shape:SolidMolecular weight:318.4Arofylline
CAS:Arofylline (LAS 31025) is a PDE4 inhibitor and can be used for asthma studies.Formula:C14H13ClN4O2Purity:98.19%Color and Shape:SolidMolecular weight:304.73Dazonone
CAS:Dazonone (Imidazo[2,1-b]quinazolin-2(3H)-one, 6-chloro-1,5-dihydro-3-methyl-) is a specific PDE III inhibitors.Formula:C11H10ClN3OPurity:99.54% - 99.73%Color and Shape:SolidMolecular weight:235.67Ref: TM-T9871
1mg73.00€5mg149.00€10mg213.00€25mg319.00€50mg450.00€100mg605.00€200mg802.00€1mL*10mM (DMSO)131.00€Menabitan dihydrochloride
CAS:Menabitan dihydrochloride (SP-204 dihydrochloride), the dihydrochloride salt of Menabitan, serves as a non-opioid analgesic agent by inhibiting phosphodiesterase 9 (PDE 9). Additionally, it has been shown to reduce intraocular pressure in a rabbit model .Formula:C37H58Cl2N2O3Color and Shape:SolidMolecular weight:649.77UK 227786
CAS:UK 227786 is an inhibitor of phosphodiesterase 5 (PDE5), used for treatment of prostatic diseases.Formula:C22H22Cl2N4O4Purity:99.9%Color and Shape:SoildMolecular weight:477.34Ref: TM-T11220L
1mg115.00€2mg172.00€5mg255.00€10mg375.00€25mg562.00€50mg792.00€100mg1,064.00€500mg2,147.00€1mL*10mM (DMSO)304.00€BAY 2666605
CAS:BAY 2666605 is an orally active inhibitor of PDE3A and PDE3B with IC50s of 87 nM and 50 nM, respectively. BAY 2666605 has anticancer effects.Formula:C17H12F4N2O2Purity:99.81%Color and Shape:SolidMolecular weight:352.28Ref: TM-T9805
1mg97.00€5mg235.00€10mg376.00€25mg828.00€50mg1,320.00€100mg2,118.00€1mL*10mM (DMSO)259.00€Acetildenafil
CAS:Acetildenafil is an analog of the phosphodiesterase inhibitor sildenafil.Formula:C25H34N6O3Color and Shape:Off-White To Pale Yelow SolidMolecular weight:466.58OPC18750 HCl
CAS:OPC18750 HCl is a phosphodiesterase inhibitor with positive inotropic effects that can be used to study asthma, cancer, diabetes, and psychiatric disorders.Formula:C20H23ClN2O4Purity:98.92%Color and Shape:SoildMolecular weight:390.86Ref: TM-T83974
1mg185.00€5mg459.00€10mg657.00€25mg1,026.00€50mg1,415.00€100mg1,872.00€1mL*10mM (DMSO)47.00€Theodrenaline hydrochloride
CAS:Theodrenaline hydrochloride is an inhibitor targeting SARS-CoV-2 for the study of hypotension induced by spinal anesthesia.Formula:C17H22ClN5O5Purity:97.05% - 98.18%Color and Shape:SoildMolecular weight:411.84Nerandomilast
CAS:Nerandomilast (BI 1015550) is an orally active PDE4B inhibitor with IC50 of 7.2 nM.Cost-effective and quality-assured.Formula:C20H25ClN6O2SPurity:98.06% - 99.96%Color and Shape:SoildMolecular weight:448.97Oglemilast
CAS:Oglemilast (GRC 3886) suppresses pulmonary cell infiltration, including eosinophilia and neutrophilia in vitro and in vivo.Formula:C20H13Cl2F2N3O5SPurity:99.82%Color and Shape:SolidMolecular weight:516.3PDE10A-IN-5
PDE10A-IN-5 (Compound A30) is an orally active inhibitor of phosphodiesterase 10A (PDE10A) with an IC50 value of 3.5 nM. By inhibiting PDE10A, it activates the cyclic adenosine monophosphate (cAMP)-related signaling pathway, exhibiting activity against pulmonary vascular remodeling. This compound is applicable to research in the field of pulmonary arterial hypertension.Color and Shape:Odour SolidEnpp-1-IN-27
Enpp-1-IN-27 is a selective ENPP1 inhibitor with an IC50 of 14.68 nM, exhibiting approximately 410-fold selectivity over ENPP2 and roughly 10-fold selectivity over ENPP3. This compound stabilizes cGAMP levels and activates the STING pathway, leading to cytokine release and an enhanced innate immune response. In addition, Enpp-1-IN-27 activates ISRE and boosts cGAMP-mediated immune responses, demonstrating significant antitumor effects in 4T1 and CT26 syngeneic mouse models. It is applicable to breast cancer and colon cancer research.Color and Shape:Odour SolidJNJ 42396302
CAS:JNJ 42396302 is an effective PDE10A inhibitor that enhances motility and viability in human sperm cells.Formula:C19H23N5O2Purity:99.36%Color and Shape:SolidMolecular weight:353.42cis-Tadalafil
CAS:Tadalafil: a carboline-based PDE5 inhibitor, treats erectile dysfunction, prostatic hyperplasia, and pulmonary hypertension.
Formula:C22H19N3O4Purity:99.89%Color and Shape:SolidMolecular weight:389.4Anti-ALDH7A1 Antibody (5P692)
Anti-ALDH7A1 Antibody (5P692) is a Rabbit antibody targeting ALDH7A1. Anti-ALDH7A1 Antibody (5P692) can be used in FCM,ICC/IF.Color and Shape:Odour LiquidAnti-ALDH7A1 Antibody (3P955)
Anti-ALDH7A1 Antibody (3P955) is a Rabbit antibody targeting ALDH7A1. Anti-ALDH7A1 Antibody (3P955) can be used in WB,ELISA,IP.Color and Shape:Odour LiquidBAY 73-6691 racemate
CAS:BAY 73-6691 racemate (Rac-BAY 73-6691) is a phosphodiesterase 9A (PDE9A) inhibitor, useful for studying Parkinson’s disease.Formula:C15H12ClF3N4OColor and Shape:SolidMolecular weight:356.73N-Ethyl tadalafil
CAS:N-Ethyl tadalafil (NEthyl tadalafil) is a PDE inhibitor used in the study of cardiovascular disease.Formula:C23H21N3O4Purity:99.58%Color and Shape:SolidMolecular weight:403.43

